Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001085146-24-005821
Filing Date
2024-11-14
Accepted
2024-11-14 12:18:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 KYNAM CAPITAL MANAGEMENT, LP dvax_111424.htm SC 13G 42609
  Complete submission text file 0001085146-24-005821.txt   44153
Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Subject) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-80035 | Film No.: 241459278
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 221 ELM ROAD PRINCETON NJ 08540
Business Address 221 ELM ROAD PRINCETON NJ 08540 212-659-3970
Kynam Capital Management, LP (Filed by) CIK: 0001907884 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G